The University of Chicago Header Logo

Connection

Ayman Al-Hendy to Humans

This is a "connection" page, showing publications Ayman Al-Hendy has written about Humans.
Connection Strength

2.986
  1. Empowering Strategies for Lifestyle Interventions, Diet Modifications, and Environmental Practices for Uterine Fibroid Prevention; Unveiling the LIFE UP Awareness. Nutrients. 2024 Mar 12; 16(6).
    View in: PubMed
    Score: 0.032
  2. Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms. Nutrients. 2024 Feb 17; 16(4).
    View in: PubMed
    Score: 0.032
  3. The potent paracrine effect of umbilical cord mesenchymal stem cells mediates mitochondrial quality control to restore chemotherapy-induced damage in ovarian granulosa cells. Biomed Pharmacother. 2024 Mar; 172:116263.
    View in: PubMed
    Score: 0.032
  4. Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids. BMJ Open. 2024 01 12; 14(1):e078989.
    View in: PubMed
    Score: 0.032
  5. Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells. Int J Mol Sci. 2024 Jan 11; 25(2).
    View in: PubMed
    Score: 0.032
  6. Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma. Cells. 2023 12 13; 12(24).
    View in: PubMed
    Score: 0.032
  7. Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach). Int J Mol Sci. 2023 Nov 04; 24(21).
    View in: PubMed
    Score: 0.031
  8. Current and Emerging Treatment Options for Uterine Fibroids. Drugs. 2023 Dec; 83(18):1649-1675.
    View in: PubMed
    Score: 0.031
  9. Endocrine-disrupting chemicals and epigenetic reprogramming in developmental origin of uterine fibroids. Sci Prog. 2023 Oct-Dec; 106(4):368504231215601.
    View in: PubMed
    Score: 0.031
  10. The combination of natural compounds Crila and epigallocatechin gallate showed enhanced antiproliferative effects on human uterine fibroid cells compared with single treatments. F S Sci. 2023 11; 4(4):341-349.
    View in: PubMed
    Score: 0.031
  11. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids. Am J Obstet Gynecol. 2023 12; 229(6):662.e1-662.e25.
    View in: PubMed
    Score: 0.031
  12. GnRH agonists and antagonists in therapy of symptomatic uterine fibroids - current roles and future perspectives. Expert Opin Pharmacother. 2023 Sep-Dec; 24(16):1799-1809.
    View in: PubMed
    Score: 0.031
  13. Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy). Adv Ther. 2023 10; 40(10):4127-4133.
    View in: PubMed
    Score: 0.031
  14. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids. J Comp Eff Res. 2023 08; 12(8):e230069.
    View in: PubMed
    Score: 0.031
  15. Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids. Int J Mol Sci. 2023 Jul 19; 24(14).
    View in: PubMed
    Score: 0.031
  16. Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial. F S Sci. 2023 Nov; 4(4):317-326.
    View in: PubMed
    Score: 0.031
  17. Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles to Treat PCOS. Int J Mol Sci. 2023 Jul 06; 24(13).
    View in: PubMed
    Score: 0.031
  18. Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage. Stem Cell Res Ther. 2023 06 20; 14(1):165.
    View in: PubMed
    Score: 0.031
  19. A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies. Pain Manag. 2023 Apr; 13(4):205-211.
    View in: PubMed
    Score: 0.030
  20. EZH2 activates Wnt/ß-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate. F S Sci. 2023 08; 4(3):239-256.
    View in: PubMed
    Score: 0.030
  21. The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma. Int J Mol Sci. 2023 Apr 27; 24(9).
    View in: PubMed
    Score: 0.030
  22. Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics. Cells. 2023 04 09; 12(8).
    View in: PubMed
    Score: 0.030
  23. Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids. Int J Mol Sci. 2023 Mar 17; 24(6).
    View in: PubMed
    Score: 0.030
  24. Gene Expression Profile of Uterine Leiomyoma from Women Exposed to Different Air Pollution Levels in Metropolitan Cities of Sao Paulo, Brazil. Int J Mol Sci. 2023 Jan 26; 24(3).
    View in: PubMed
    Score: 0.030
  25. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials. Am J Obstet Gynecol. 2023 03; 228(3):320.e1-320.e11.
    View in: PubMed
    Score: 0.029
  26. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas. Obstet Gynecol. 2022 12 01; 140(6):920-930.
    View in: PubMed
    Score: 0.029
  27. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022 07 13; 43(4):678-719.
    View in: PubMed
    Score: 0.029
  28. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma. Cells. 2022 07 10; 11(14).
    View in: PubMed
    Score: 0.029
  29. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials. Obstet Gynecol. 2022 06 01; 139(6):1070-1081.
    View in: PubMed
    Score: 0.028
  30. Non-Cytokine Protein Profile of the Mesenchymal Stem Cell Secretome That Regulates the Androgen Production Pathway. Int J Mol Sci. 2022 Apr 22; 23(9).
    View in: PubMed
    Score: 0.028
  31. The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer. Cells. 2022 03 29; 11(7).
    View in: PubMed
    Score: 0.028
  32. Stem Cell Therapy: From Idea to Clinical Practice. Int J Mol Sci. 2022 Mar 05; 23(5).
    View in: PubMed
    Score: 0.028
  33. Development of Obstetric Practice During the Early Islamic Era. Reprod Sci. 2022 09; 29(9):2587-2592.
    View in: PubMed
    Score: 0.028
  34. Epigenetic Regulation in Uterine Fibroids-The Role of Ten-Eleven Translocation Enzymes and Their Potential Therapeutic Application. Int J Mol Sci. 2022 Feb 28; 23(5).
    View in: PubMed
    Score: 0.028
  35. An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Expert Opin Pharmacother. 2022 Mar; 23(4):421-429.
    View in: PubMed
    Score: 0.028
  36. What Is the Mechanism of Poor Endometrial Proliferation in Patients With Unexplained Infertility After Clomiphene Citrate Treatment? J Clin Endocrinol Metab. 2021 10 21; 106(11):e4776-e4777.
    View in: PubMed
    Score: 0.027
  37. Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids. Expert Opin Drug Saf. 2022 Apr; 21(4):477-486.
    View in: PubMed
    Score: 0.027
  38. Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids. J Womens Health (Larchmt). 2022 05; 31(5):698-705.
    View in: PubMed
    Score: 0.027
  39. Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis and Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2. Int J Mol Sci. 2021 Aug 25; 22(17).
    View in: PubMed
    Score: 0.027
  40. Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10. Stem Cell Res Ther. 2021 07 07; 12(1):388.
    View in: PubMed
    Score: 0.027
  41. Reproductive Tract Tissue/Organ Engineering and Regenerative Medicine for Reproduction. Reprod Sci. 2021 06; 28(6):1571-1572.
    View in: PubMed
    Score: 0.027
  42. Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency. Reprod Sci. 2021 06; 28(6):1688-1696.
    View in: PubMed
    Score: 0.026
  43. Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model. Sci Rep. 2021 02 25; 11(1):4525.
    View in: PubMed
    Score: 0.026
  44. Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy. Int J Mol Sci. 2021 Feb 22; 22(4).
    View in: PubMed
    Score: 0.026
  45. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy. N Engl J Med. 2021 02 18; 384(7):630-642.
    View in: PubMed
    Score: 0.026
  46. Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model. Cell Transplant. 2021 Jan-Dec; 30:963689720988502.
    View in: PubMed
    Score: 0.026
  47. The Significance of Measuring Vitamin D Serum Levels in Women with Uterine Fibroids. Reprod Sci. 2021 08; 28(8):2098-2109.
    View in: PubMed
    Score: 0.026
  48. Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility. Cells. 2020 10 08; 9(10).
    View in: PubMed
    Score: 0.025
  49. Vitamins and Uterine Fibroids: Current Data on Pathophysiology and Possible Clinical Relevance. Int J Mol Sci. 2020 Aug 01; 21(15).
    View in: PubMed
    Score: 0.025
  50. Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature. J Med Case Rep. 2020 Jul 18; 14(1):108.
    View in: PubMed
    Score: 0.025
  51. Evolving role of microRNAs in uterine fibroid pathogenesis: filling the gap! Fertil Steril. 2020 06; 113(6):1167-1168.
    View in: PubMed
    Score: 0.025
  52. Molecular Bio-Imaging Probe for Non-Invasive Differentiation Between Human Leiomyoma Versus Leiomyosarcoma. Reprod Sci. 2020 02; 27(2):644-654.
    View in: PubMed
    Score: 0.024
  53. Alcohol Consumption and Risk of Uterine Fibroids. Curr Mol Med. 2020; 20(4):247-258.
    View in: PubMed
    Score: 0.024
  54. Vision 20/20 for the Second Leap of Reproductive Sciences. Reprod Sci. 2020 01; 27(1):1-2.
    View in: PubMed
    Score: 0.024
  55. Vitamin D and uterine fibroids: preclinical evidence is in; time for an overdue clinical study! Fertil Steril. 2020 01; 113(1):89-90.
    View in: PubMed
    Score: 0.024
  56. Simvastatin and uterine fibroids: opportunity for a novel therapeutic option. Fertil Steril. 2018 12; 110(7):1272-1273.
    View in: PubMed
    Score: 0.022
  57. Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells. Biol Reprod. 2018 10 01; 99(4):735-748.
    View in: PubMed
    Score: 0.022
  58. Uterine fibroid therapy: the pharmacokinetic considerations. Expert Opin Drug Metab Toxicol. 2018 Sep; 14(9):887-889.
    View in: PubMed
    Score: 0.022
  59. Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment. Am J Pathol. 2018 10; 188(10):2293-2306.
    View in: PubMed
    Score: 0.022
  60. Non-coding RNAs: an important regulatory mechanism in pathogenesis of uterine fibroids. Fertil Steril. 2018 05; 109(5):802-803.
    View in: PubMed
    Score: 0.021
  61. Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol. 2018 03; 131(3):431-439.
    View in: PubMed
    Score: 0.021
  62. Successes and failures of uterine leiomyoma drug discovery. Expert Opin Drug Discov. 2018 02; 13(2):169-177.
    View in: PubMed
    Score: 0.021
  63. Uterine Leiomyoma: New Perspectives on an Old Disease. Semin Reprod Med. 2017 11; 35(6):471-472.
    View in: PubMed
    Score: 0.021
  64. Uterine Fibroids: Burden and Unmet Medical Need. Semin Reprod Med. 2017 11; 35(6):473-480.
    View in: PubMed
    Score: 0.021
  65. Origin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells. Semin Reprod Med. 2017 11; 35(6):481-486.
    View in: PubMed
    Score: 0.021
  66. Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids. Biol Reprod. 2017 Sep 01; 97(3):337-352.
    View in: PubMed
    Score: 0.021
  67. Human Mesenchymal Stem Cells Partially Reverse Infertility in Chemotherapy-Induced Ovarian Failure. Reprod Sci. 2018 01; 25(1):51-63.
    View in: PubMed
    Score: 0.020
  68. Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/ß-Catenin Signaling Pathway. Endocrinology. 2017 03 01; 158(3):592-603.
    View in: PubMed
    Score: 0.020
  69. Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications. Reprod Sci. 2017 09; 24(9):1235-1244.
    View in: PubMed
    Score: 0.019
  70. Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis. Stem Cells. 2017 03; 35(3):666-678.
    View in: PubMed
    Score: 0.019
  71. Hypovitaminosis D and high serum transforming growth factor beta-3: important biomarkers for uterine fibroids risk. Fertil Steril. 2016 12; 106(7):1648-1649.
    View in: PubMed
    Score: 0.019
  72. Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids. Reprod Sci. 2016 10; 23(10):1314-25.
    View in: PubMed
    Score: 0.019
  73. Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells. Fertil Steril. 2016 06; 105(6):1638-1648.e8.
    View in: PubMed
    Score: 0.019
  74. The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids. Biol Reprod. 2016 Mar; 94(3):69.
    View in: PubMed
    Score: 0.018
  75. Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for In Vivo Gene Therapy of Uterine Leiomyoma. Reprod Sci. 2016 Apr; 23(4):464-74.
    View in: PubMed
    Score: 0.018
  76. Enhancing Adenoviral-Mediated Gene Transfer and Expression to Endometrial Cells. Reprod Sci. 2016 08; 23(8):1109-15.
    View in: PubMed
    Score: 0.018
  77. Vitamin D3 Inhibits Wnt/ß-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells. J Clin Endocrinol Metab. 2016 04; 101(4):1542-51.
    View in: PubMed
    Score: 0.018
  78. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development. Reprod Sci. 2016 Feb; 23(2):163-75.
    View in: PubMed
    Score: 0.017
  79. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells. J Clin Endocrinol Metab. 2015 Apr; 100(4):E572-82.
    View in: PubMed
    Score: 0.017
  80. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids. Mol Genet Genomics. 2015 Apr; 290(2):505-11.
    View in: PubMed
    Score: 0.017
  81. Sertoli-Leydig cell tumor with unique nail findings in a post-menopausal woman: a case report and literature review. J Ovarian Res. 2014 Aug 28; 7:83.
    View in: PubMed
    Score: 0.017
  82. Can vitamin D reduce the risk of uterine fibroids? Womens Health (Lond). 2014 Jul; 10(4):353-8.
    View in: PubMed
    Score: 0.016
  83. Green tea extract inhibition of human leiomyoma cell proliferation is mediated via catechol-O-methyltransferase. Gynecol Obstet Invest. 2014; 78(2):109-18.
    View in: PubMed
    Score: 0.016
  84. Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids. Reprod Sci. 2014 Sep; 21(9):1108-19.
    View in: PubMed
    Score: 0.016
  85. Krukenberg tumor presenting as back pain and a positive urine pregnancy test: a case report and literature review. J Ovarian Res. 2014 Apr 07; 7:36.
    View in: PubMed
    Score: 0.016
  86. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod. 2013 Dec; 89(6):150.
    View in: PubMed
    Score: 0.016
  87. Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma. Semin Reprod Med. 2013 Sep; 31(5):370-9.
    View in: PubMed
    Score: 0.015
  88. Towards gene therapy of postoperative adhesions: fiber and transcriptional modifications enhance adenovirus targeting towards human adhesion cells. Gynecol Obstet Invest. 2013; 76(2):119-24.
    View in: PubMed
    Score: 0.015
  89. Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas. Hum Reprod. 2013 Sep; 28(9):2398-406.
    View in: PubMed
    Score: 0.015
  90. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013 Sep; 28(9):2407-16.
    View in: PubMed
    Score: 0.015
  91. 1,25-Dihydroxyvitamin D deficiency is associated with preterm birth in African American and Caucasian women. Reprod Sci. 2014 Feb; 21(2):244-50.
    View in: PubMed
    Score: 0.015
  92. Vitamin D elicits anti-inflammatory response, inhibits contractile-associated proteins, and modulates Toll-like receptors in human myometrial cells. Reprod Sci. 2013 Apr; 20(4):463-75.
    View in: PubMed
    Score: 0.015
  93. Medical treatment of uterine leiomyoma. Reprod Sci. 2012 Apr; 19(4):339-53.
    View in: PubMed
    Score: 0.014
  94. A single-nucleotide polymorphism in the fetal catechol-O-methyltransferase gene is associated with spontaneous preterm birth in African Americans. Reprod Sci. 2012 Feb; 19(2):135-42.
    View in: PubMed
    Score: 0.014
  95. Adipocytes enhance the proliferation of human leiomyoma cells via TNF-a proinflammatory cytokine. Reprod Sci. 2011 Dec; 18(12):1186-92.
    View in: PubMed
    Score: 0.014
  96. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril. 2011 Jan; 95(1):247-53.
    View in: PubMed
    Score: 0.013
  97. Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(-/-) FORKO mice. Mol Hum Reprod. 2010 Apr; 16(4):241-50.
    View in: PubMed
    Score: 0.012
  98. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil Steril. 2010 Oct; 94(5):1887-93.
    View in: PubMed
    Score: 0.012
  99. Elevated expression of catechol-O-methyltransferase is associated with labor and increased prostaglandin E(2) production by human fetal membranes. Am J Obstet Gynecol. 2009 Nov; 201(5):496.e1-7.
    View in: PubMed
    Score: 0.012
  100. Gene therapy of benign gynecological diseases. Adv Drug Deliv Rev. 2009 Aug 10; 61(10):822-35.
    View in: PubMed
    Score: 0.012
  101. Toward gene therapy of endometriosis: transductional and transcriptional targeting of adenoviral vectors to endometriosis cells. Am J Obstet Gynecol. 2008 Aug; 199(2):117.e1-6.
    View in: PubMed
    Score: 0.011
  102. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. Am J Obstet Gynecol. 2008 Aug; 199(2):156.e1-8.
    View in: PubMed
    Score: 0.011
  103. Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2008 Aug; 22(4):589-601.
    View in: PubMed
    Score: 0.011
  104. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells? Breast Cancer Res Treat. 2009 Jan; 113(1):9-19.
    View in: PubMed
    Score: 0.011
  105. Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cells. Hum Reprod. 2008 Mar; 23(3):514-24.
    View in: PubMed
    Score: 0.011
  106. Progesterone-mediated regulation of catechol-O-methyl transferase expression in endometrial cancer cells. Reprod Sci. 2008 Feb; 15(2):210-20.
    View in: PubMed
    Score: 0.010
  107. Toward gene therapy of primary ovarian failure: adenovirus expressing human FSH receptor corrects the Finnish C566T mutation. Mol Hum Reprod. 2008 Jan; 14(1):9-15.
    View in: PubMed
    Score: 0.010
  108. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome. Fertil Steril. 2008 May; 89(5 Suppl):1414-21.
    View in: PubMed
    Score: 0.010
  109. Progesterone regulates catechol-O-methyl transferase gene expression in breast cancer cells: distinct effect of progesterone receptor isoforms. J Steroid Biochem Mol Biol. 2007 Nov-Dec; 107(3-5):253-61.
    View in: PubMed
    Score: 0.010
  110. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008 Apr; 137(2):240-6.
    View in: PubMed
    Score: 0.010
  111. Lower levels of urinary 2-hydroxyestrogens in polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Aug; 92(8):3285-91.
    View in: PubMed
    Score: 0.010
  112. Expression and cyclic variations of catechol-O-methyl transferase in human endometrial stroma. Fertil Steril. 2008 Sep; 90(3):789-97.
    View in: PubMed
    Score: 0.010
  113. Toward gene therapy of endometriosis: adenovirus-mediated delivery of dominant negative estrogen receptor genes inhibits cell proliferation, reduces cytokine production, and induces apoptosis of endometriotic cells. Fertil Steril. 2007 Aug; 88(2):462-71.
    View in: PubMed
    Score: 0.010
  114. Regulation of catechol-O-methyltransferase expression in human myometrial cells. Obstet Gynecol. 2006 Dec; 108(6):1439-47.
    View in: PubMed
    Score: 0.010
  115. Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene. Gynecol Oncol. 2007 Feb; 104(2):276-80.
    View in: PubMed
    Score: 0.010
  116. Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids. J Soc Gynecol Investig. 2006 Dec; 13(8):542-50.
    View in: PubMed
    Score: 0.010
  117. Gene therapy of uterine leiomyoma: adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir treatment inhibits growth of human and rat leiomyoma cells in vitro and in a nude mouse model. Gynecol Obstet Invest. 2007; 63(2):61-70.
    View in: PubMed
    Score: 0.010
  118. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril. 2006 Sep; 86(3):686-93.
    View in: PubMed
    Score: 0.009
  119. Hormonal regulation of catechol-O-methyl transferase activity in women with uterine leiomyomas. Fertil Steril. 2006 Jul; 86(1):259-62.
    View in: PubMed
    Score: 0.009
  120. Gene therapy and uterine leiomyoma: a review. Hum Reprod Update. 2006 Jul-Aug; 12(4):385-400.
    View in: PubMed
    Score: 0.009
  121. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006 Feb; 13(2):136-44.
    View in: PubMed
    Score: 0.009
  122. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol. 2004 Nov; 191(5):1621-31.
    View in: PubMed
    Score: 0.008
  123. Early modulation of the gut microbiome by female sex hormones alters amyloid pathology and microglial function. Sci Rep. 2024 01 21; 14(1):1827.
    View in: PubMed
    Score: 0.008
  124. Fertility Protection, A Novel Concept: Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Protect against Chemotherapy-Induced Testicular Cytotoxicity. Int J Mol Sci. 2023 Dec 20; 25(1).
    View in: PubMed
    Score: 0.008
  125. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study. Am J Obstet Gynecol. 2024 Feb; 230(2):237.e1-237.e11.
    View in: PubMed
    Score: 0.008
  126. Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set. BJOG. 2023 10; 130(11):1337-1345.
    View in: PubMed
    Score: 0.008
  127. Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women. Nutrients. 2023 Jan 09; 15(2).
    View in: PubMed
    Score: 0.007
  128. Gut and genital tract microbiomes: Dysbiosis and link to gynecological disorders. Front Cell Infect Microbiol. 2022; 12:1059825.
    View in: PubMed
    Score: 0.007
  129. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma. Cells. 2022 Nov 27; 11(23).
    View in: PubMed
    Score: 0.007
  130. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. Lancet. 2022 09 17; 400(10356):896-907.
    View in: PubMed
    Score: 0.007
  131. Human Myometrial and Uterine Fibroid Stem Cell-Derived Organoids for Intervening the Pathophysiology of Uterine Fibroid. Reprod Sci. 2022 09; 29(9):2607-2619.
    View in: PubMed
    Score: 0.007
  132. Adverse childhood experiences and health-related quality of life among women undergoing hysterectomy for uterine leiomyoma. Am J Obstet Gynecol. 2022 08; 227(2):351-353.e5.
    View in: PubMed
    Score: 0.007
  133. A Call-to-Action for Clinicians to Implement Evidence-Based Best Practices When Caring for Women with Uterine Fibroids. Reprod Sci. 2022 04; 29(4):1188-1196.
    View in: PubMed
    Score: 0.007
  134. Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-ß3 and Wnt/ß-Catenin pathways. J Cell Mol Med. 2022 03; 26(5):1684-1698.
    View in: PubMed
    Score: 0.007
  135. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model. Reprod Sci. 2022 03; 29(3):781-790.
    View in: PubMed
    Score: 0.007
  136. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation. Pharmacol Res. 2021 10; 172:105856.
    View in: PubMed
    Score: 0.007
  137. Bone Mineral Density Changes Associated With Pregnancy, Lactation, and Medical Treatments in Premenopausal Women and Effects Later in Life. J Womens Health (Larchmt). 2021 10; 30(10):1416-1430.
    View in: PubMed
    Score: 0.007
  138. Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients. Sci Rep. 2021 04 30; 11(1):9371.
    View in: PubMed
    Score: 0.007
  139. Nutrition in Gynecological Diseases: Current Perspectives. Nutrients. 2021 Apr 02; 13(4).
    View in: PubMed
    Score: 0.007
  140. Targeting Hedgehog Pathway and DNA Methyltransferases in Uterine Leiomyosarcoma Cells. Cells. 2020 12 31; 10(1).
    View in: PubMed
    Score: 0.006
  141. The role of endocrine-disrupting chemicals in uterine fibroid pathogenesis. Curr Opin Endocrinol Diabetes Obes. 2020 12; 27(6):380-387.
    View in: PubMed
    Score: 0.006
  142. Summary of the Proceedings of the Basic Science of Uterine Fibroids Meeting: New Developments February 28, 2020. F S Sci. 2021 02; 2(1):88-100.
    View in: PubMed
    Score: 0.006
  143. Non-hormonal mediators of uterine fibroid growth. Curr Opin Obstet Gynecol. 2020 10; 32(5):361-370.
    View in: PubMed
    Score: 0.006
  144. Association between mutations of the follicle-stimulating-hormone receptor and repeated twinning. Lancet. 2000 Sep 09; 356(9233):914.
    View in: PubMed
    Score: 0.006
  145. Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstet Gynecol. 2020 06; 135(6):1313-1326.
    View in: PubMed
    Score: 0.006
  146. Activation of ß-Catenin Signaling and its Crosstalk With Estrogen and Histone Deacetylases in Human Uterine Fibroids. J Clin Endocrinol Metab. 2020 04 01; 105(4).
    View in: PubMed
    Score: 0.006
  147. The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor. J Clin Endocrinol Metab. 2020 03 01; 105(3).
    View in: PubMed
    Score: 0.006
  148. Uterine fibroids in menopause and perimenopause. Menopause. 2020 02; 27(2):238-242.
    View in: PubMed
    Score: 0.006
  149. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids. N Engl J Med. 2020 01 23; 382(4):328-340.
    View in: PubMed
    Score: 0.006
  150. Introduction of Somatic Mutation in MED12 Induces Wnt4/ß-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell. Reprod Sci. 2020 03; 27(3):823-832.
    View in: PubMed
    Score: 0.006
  151. Neurotrimin: a novel neural cell adhesion molecule correlating with uterine fibroid phenotype. Fertil Steril. 2020 01; 113(1):83-84.
    View in: PubMed
    Score: 0.006
  152. Enriching research culture in residency. Am J Obstet Gynecol. 1999 Nov; 181(5 Pt 1):1271.
    View in: PubMed
    Score: 0.006
  153. Myometrial progesterone hyper-responsiveness associated with increased risk of human uterine fibroids. BMC Womens Health. 2019 07 09; 19(1):92.
    View in: PubMed
    Score: 0.006
  154. H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas. Oncogene. 2019 07; 38(27):5356-5366.
    View in: PubMed
    Score: 0.006
  155. Targeting the transforming growth factor-ß pathway: a novel mechanism of ulipristal acetate action against uterine fibroids. Fertil Steril. 2019 04; 111(4):683-684.
    View in: PubMed
    Score: 0.006
  156. Vitamin D, a promising natural compound with anti-uterine fibroid characteristics. Fertil Steril. 2019 02; 111(2):268-269.
    View in: PubMed
    Score: 0.006
  157. 1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids. Reprod Sci. 2019 06; 26(6):812-828.
    View in: PubMed
    Score: 0.006
  158. Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment. Acta Pharmacol Sin. 2019 Jul; 40(7):957-970.
    View in: PubMed
    Score: 0.006
  159. Mediator Kinase Disruption in MED12-Mutant Uterine Fibroids From Hispanic Women of South Texas. J Clin Endocrinol Metab. 2018 11 01; 103(11):4283-4292.
    View in: PubMed
    Score: 0.006
  160. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol. 2018 11; 132(5):1252-1264.
    View in: PubMed
    Score: 0.006
  161. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. J Womens Health (Larchmt). 2018 11; 27(11):1359-1367.
    View in: PubMed
    Score: 0.006
  162. A Preliminary Study: Human Fibroid Stro-1+/CD44+ Stem Cells Isolated From Uterine Fibroids Demonstrate Decreased DNA Repair and Genomic Integrity Compared to Adjacent Myometrial Stro-1+/CD44+ Cells. Reprod Sci. 2019 05; 26(5):619-638.
    View in: PubMed
    Score: 0.005
  163. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19. J Biol Chem. 2018 03 30; 293(13):4870-4882.
    View in: PubMed
    Score: 0.005
  164. Uterine Fibroids: Bridging Genomic Defects and Chronic Inflammation. Semin Reprod Med. 2017 11; 35(6):494-498.
    View in: PubMed
    Score: 0.005
  165. Vitamin D and corticotropin-releasing hormone in term and preterm birth: potential contributions to preterm labor and birth outcome. J Matern Fetal Neonatal Med. 2018 Nov; 31(21):2911-2917.
    View in: PubMed
    Score: 0.005
  166. Oxidative stress: a key regulator of leiomyoma cell survival. Fertil Steril. 2017 06; 107(6):1387-1394.e1.
    View in: PubMed
    Score: 0.005
  167. Applying the herpes simplex virus thymidine kinase/ganciclovir approach to ovarian cancer: an effective in vitro drug-sensitization system. Gynecol Obstet Invest. 1997; 43(4):268-75.
    View in: PubMed
    Score: 0.005
  168. Modified Adenovirus Reduces De Novo Peritoneal Adhesions in Rats and Limits Off-Target Transfection. Role of EZH2 in Adhesion Formation. J Invest Surg. 2017 Apr; 30(2):78-87.
    View in: PubMed
    Score: 0.005
  169. Use of uterine artery embolization to prevent peripartum hemorrhage of placental abruption with fetal demise & severe DIC. J Neonatal Perinatal Med. 2016 Sep 16; 9(3):325-31.
    View in: PubMed
    Score: 0.005
  170. Opinions and Practice of US-Based Obstetrician-Gynecologists regarding Vitamin D Screening and Supplementation of Pregnant Women. J Pregnancy. 2016; 2016:1454707.
    View in: PubMed
    Score: 0.005
  171. Endocrine-disrupting chemicals and uterine fibroids. Fertil Steril. 2016 09 15; 106(4):967-77.
    View in: PubMed
    Score: 0.005
  172. Soluble tumor necrosis factor-alpha receptors in the serum of endometriosis patients. Eur J Obstet Gynecol Reprod Biol. 2016 May; 200:1-5.
    View in: PubMed
    Score: 0.005
  173. Atypical Presentations of Molar Pregnancy: Diagnostic Roles of Imaging, ß-Human Chorionic Gonadotropin Measurement, and p57 Immunostaining. J Ultrasound Med. 2016 Mar; 35(3):643-9.
    View in: PubMed
    Score: 0.005
  174. Growth retardation--an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts. Hum Gene Ther. 1996 Jan; 7(1):61-70.
    View in: PubMed
    Score: 0.005
  175. Role of vitamin D in uterine fibroid biology. Fertil Steril. 2015 Sep; 104(3):698-706.
    View in: PubMed
    Score: 0.004
  176. Stro-1/CD44 as putative human myometrial and fibroid stem cell markers. Fertil Steril. 2015 Jul; 104(1):225-34.e3.
    View in: PubMed
    Score: 0.004
  177. Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy. Mol Med. 2015 Apr 13; 21:242-56.
    View in: PubMed
    Score: 0.004
  178. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study. Am J Obstet Gynecol. 2015 Aug; 213(2):196.e1-8.
    View in: PubMed
    Score: 0.004
  179. Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise. J Minim Invasive Gynecol. 2015 Jul-Aug; 22(5):719-26.
    View in: PubMed
    Score: 0.004
  180. Berberine inhibits the proliferation of human uterine leiomyoma cells. Fertil Steril. 2015 Apr; 103(4):1098-106.
    View in: PubMed
    Score: 0.004
  181. Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression. PLoS One. 2014; 9(11):e112384.
    View in: PubMed
    Score: 0.004
  182. Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells. J Biol Chem. 2014 Dec 19; 289(51):35075-86.
    View in: PubMed
    Score: 0.004
  183. FSH receptor (FSHR) expression in human extragonadal reproductive tissues and the developing placenta, and the impact of its deletion on pregnancy in mice. Biol Reprod. 2014 Sep; 91(3):74.
    View in: PubMed
    Score: 0.004
  184. Nicotinamide adenine dinucleotide phosphate oxidase is differentially regulated in normal myometrium versus leiomyoma. Reprod Sci. 2014 Sep; 21(9):1145-52.
    View in: PubMed
    Score: 0.004
  185. Vitamin D regulates contractile profile in human uterine myometrial cells via NF-?B pathway. Am J Obstet Gynecol. 2014 Apr; 210(4):347.e1-347.e10.
    View in: PubMed
    Score: 0.004
  186. Uterine fibroids are characterized by an impaired antioxidant cellular system: potential role of hypoxia in the pathophysiology of uterine fibroids. J Assist Reprod Genet. 2013 Jul; 30(7):969-74.
    View in: PubMed
    Score: 0.004
  187. Protective cardiovascular and renal actions of vitamin D and estrogen. Front Biosci (Schol Ed). 2013 01 01; 5(1):134-48.
    View in: PubMed
    Score: 0.004
  188. Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome. Int J Gynaecol Obstet. 2012 Sep; 118(3):242-6.
    View in: PubMed
    Score: 0.004
  189. Increased COMT expression in PCOS biology. Mol Cell Endocrinol. 2012 May 15; 355(1):188-9.
    View in: PubMed
    Score: 0.003
  190. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab. 2011 Apr; 96(4):E754-62.
    View in: PubMed
    Score: 0.003
  191. Adenovirus-mediated overexpression of human tissue plasminogen activator prevents peritoneal adhesion formation/reformation in rats. Surgery. 2009 Jul; 146(1):12-7.
    View in: PubMed
    Score: 0.003
  192. Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation. Liver Int. 2009 Aug; 29(7):1022-30.
    View in: PubMed
    Score: 0.003
  193. Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase. Int J Cancer. 2008 Sep 15; 123(6):1246-54.
    View in: PubMed
    Score: 0.003
  194. Abrogation of estrogen receptor signaling augments cytotoxicity of anticancer drugs on CaSki cervical cancer cells. Anticancer Res. 2008 Jul-Aug; 28(4B):2181-7.
    View in: PubMed
    Score: 0.003
  195. Multiplexed quantitation of endogenous estrogens and estrogen metabolites in human peritoneal fluid. Electrophoresis. 2008 Jun; 29(12):2706-13.
    View in: PubMed
    Score: 0.003
  196. 2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft. Cancer Chemother Pharmacol. 2008 Oct; 62(5):893-902.
    View in: PubMed
    Score: 0.003
  197. Adenovirus-mediated expression of cyclooxygenase-2 antisense reverse abnormal genetic profile of human adhesion fibroblasts. Fertil Steril. 2008 May; 89(5 Suppl):1455-60.
    View in: PubMed
    Score: 0.003
  198. Environmental risk factors for prevention and molecular intervention of cervical cancer. Int J Hyg Environ Health. 2007 Dec; 210(6):671-678.
    View in: PubMed
    Score: 0.002
  199. Potential nonhormonal therapeutics for medical treatment of leiomyomas. Semin Reprod Med. 2004 May; 22(2):121-30.
    View in: PubMed
    Score: 0.002
  200. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood. 1996 Jun 15; 87(12):5095-103.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.